ASCO 2023 is coming up June 3 – 5, and our team at PSI is excited to join the conversation with oncology sponsors and partners like you. Stop by Booth #19020 for a chance (or schedule a meeting here) to speak with PSI experts helping to support oncology innovators across the globe. Meet our team members who are packing their bags for Chicago.
Director Project Management
Vince serves as a Director and supervisor of Project Management, overseeing PSI’s team of Project Management staff and several studies in oncology and hematology. Vince has been with PSI since December 2019, and is based in Texas. He has over 19 years’ clinical research experience, 15 years of project management experience, and has delivered 20+ oncology studies in both solid tumors and hematology-oncology.
Vince has professional affiliations with the Project Management Institute in the US and has been a certified Project Management Professional since 2012.
Emily McInturf, Director Feasibility, has worked in the clinical research industry for the past 15 years. As a leader within PSI’s global feasibility team, Emily specializes in strategy development across multiple therapeutic areas – focusing on aligning a study’s design with top enrolling investigators in the right countries.
Using PSI’s INTELIA platform, a machine-learning-powered system for data-driven feasibility and enrollment forecast, Emily models and compares hundreds of country and site combinations, their budgets and probability of success, ultimately recommending the most optimal enrollment scenario in line with each sponsor’s key objectives.
As a Director, Emily provides oversight for global feasibility and site identification activities for both pre- and post-award opportunities and projects.
Senior Director, Operations
Rhonda Critchlow, Senior Director of Therapeutic Strategy, currently oversees all of PSI’s core indications, and specializes in operational strategy within oncology and radiopharmaceuticals. With over 25 years of research experience, she provides valuable leadership and management working both regionally and globally.
Overseeing the therapeutic strategy department, which includes our Site Support Specialist, Rhonda brings guidance and oversight to specialty vendor management, patient recruitment and retention for our sponsors.
Prior to working at PSI, her experience includes working within oncology research as a Coordinator and Director, CRA, Clinical Trial Manager, Head of Monitoring and Vice President of Early Phase Oncology before joining PSI. Rhonda also has experience working with general radiology and nuclear medicine in large hospital organizations, providing valuable input for clinical development, study management and operational considerations.
Meet us at ASCO 2023
Vince, Emily, and the rest of our team are excited to discuss your upcoming oncology study at ASCO 2023. Click here to reserve your spot today.